Literature DB >> 20034769

Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.

Ki-Seok Kim1, Soo-Jin Park.   

Abstract

In this work, porous poly(epsilon-caprolactone) (PCL)/Eudragit RS 100 (ERS-100) microcapsules containing tulobuterol base as a model drug were prepared by a solvent evaporation method and the effect of the quaternary ammonium groups of ERS-100 on the release behaviors of the microcapsules was investigated. The microcapsules prepared with PCL alone showed a stable and smooth surface, whereas porous microcapsules were formed with the addition of ERS-100. Drug loading and encapsulation efficiency of the microcapsules were slightly decreased with an increase of ERS-100 content, resulting from an increase in the porosity of the microcapsules. In an acidic release medium, PCL microcapsules showed slow drug release, whereas PCL/ERS-100 microcapsules showed a faster release rate with an increasing ERS-100 content. These behaviors are likely due to an increase in the diffusion rate of the drugs stemming from an increased hydration of the microcapsules, which results from the interaction between the carboxyl group of the release medium and the quaternary ammonium group of ERS-100. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034769     DOI: 10.1016/j.colsurfb.2009.11.015

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  6 in total

1.  Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

Authors:  Ahmed Abd Elbary; Ahmed A Aboelwafa; Ibrahim M Al Sharabi
Journal:  AAPS PharmSciTech       Date:  2011-10-29       Impact factor: 3.246

2.  Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.

Authors:  Bo Xiao; Xiaoying Si; Mingzhen Zhang; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-01       Impact factor: 5.268

3.  The application of co-melt-extruded poly(ε-caprolactone) as a controlled release drug delivery device when combined with novel bioactive drug candidates: Membrane permeation and Hanson dissolution studies.

Authors:  Stephen J Gardyne; Michael R Mucalo; Michael J Rathbone
Journal:  Results Pharma Sci       Date:  2011-11-25

Review 4.  Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.

Authors:  Mallesh Kurakula; G S N Koteswara Rao
Journal:  J Drug Deliv Sci Technol       Date:  2020-09-02       Impact factor: 3.981

5.  Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.

Authors:  Touseef Nawaz; Muhammad Iqbal; Barkat Ali Khan; Asif Nawaz; Talib Hussain; Khaled M Hosny; Walaa A Abualsunun; Waleed Y Rizg
Journal:  Polymers (Basel)       Date:  2021-12-28       Impact factor: 4.329

6.  Single-Cellular Biological Effects of Cholesterol-Catabolic Bile Acid-Based Nano/Micro Capsules as Anti-Inflammatory Cell Protective Systems.

Authors:  Armin Mooranian; Corina Mihaela Ionescu; Daniel Walker; Melissa Jones; Susbin Raj Wagle; Bozica Kovacevic; Jacqueline Chester; Thomas Foster; Edan Johnston; Jafri Kuthubutheen; Daniel Brown; Marcus D Atlas; Momir Mikov; Hani Al-Salami
Journal:  Biomolecules       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.